These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 14606518)

  • 21. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
    Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
    Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations.
    Cormier S; Delezoide AL; Benoist-Lasselin C; Legeai-Mallet L; Bonaventure J; Silve C
    Am J Pathol; 2002 Oct; 161(4):1325-35. PubMed ID: 12368206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation.
    Monsonego-Ornan E; Adar R; Feferman T; Segev O; Yayon A
    Mol Cell Biol; 2000 Jan; 20(2):516-22. PubMed ID: 10611230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation.
    Hart KC; Robertson SC; Donoghue DJ
    Mol Biol Cell; 2001 Apr; 12(4):931-42. PubMed ID: 11294897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
    Jonquoy A; Mugniery E; Benoist-Lasselin C; Kaci N; Le Corre L; Barbault F; Girard AL; Le Merrer Y; Busca P; Schibler L; Munnich A; Legeai-Mallet L
    Hum Mol Genet; 2012 Feb; 21(4):841-51. PubMed ID: 22072392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.
    Cho JY; Guo C; Torello M; Lunstrum GP; Iwata T; Deng C; Horton WA
    Proc Natl Acad Sci U S A; 2004 Jan; 101(2):609-14. PubMed ID: 14699054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the phosphoinositide 3-kinase/protein kinase B signaling pathway in insulin/IGF-I-induced chondrogenesis of the mouse embryonal carcinoma-derived cell line ATDC5.
    Hidaka K; Kanematsu T; Takeuchi H; Nakata M; Kikkawa U; Hirata M
    Int J Biochem Cell Biol; 2001 Nov; 33(11):1094-103. PubMed ID: 11551825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differentiation of achondroplasia and other similar genetic dwarfism by FGFR3 gene analysis].
    Zhang Y; Yu W; Shen M; Fang Q; Fan M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):252-5. PubMed ID: 10932008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia.
    Matsushita M; Kitoh H; Ohkawara B; Mishima K; Kaneko H; Ito M; Masuda A; Ishiguro N; Ohno K
    PLoS One; 2013; 8(12):e81569. PubMed ID: 24324705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias.
    Legeai-Mallet L; Benoist-Lasselin C; Munnich A; Bonaventure J
    Bone; 2004 Jan; 34(1):26-36. PubMed ID: 14751560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice.
    Garofalo S; Kliger-Spatz M; Cooke JL; Wolstin O; Lunstrum GP; Moshkovitz SM; Horton WA; Yayon A
    J Bone Miner Res; 1999 Nov; 14(11):1909-15. PubMed ID: 10571691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF receptor mutations: dimerization syndromes, cell growth suppression, and animal models.
    Kannan K; Givol D
    IUBMB Life; 2000 Mar; 49(3):197-205. PubMed ID: 10868910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
    Logié A; Dunois-Lardé C; Rosty C; Levrel O; Blanche M; Ribeiro A; Gasc JM; Jorcano J; Werner S; Sastre-Garau X; Thiery JP; Radvanyi F
    Hum Mol Genet; 2005 May; 14(9):1153-60. PubMed ID: 15772091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line.
    Baixeras E; Jeay S; Kelly PA; Postel-Vinay MC
    Endocrinology; 2001 Jul; 142(7):2968-77. PubMed ID: 11416018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trps1 plays a pivotal role downstream of Gdf5 signaling in promoting chondrogenesis and apoptosis of ATDC5 cells.
    Itoh S; Kanno S; Gai Z; Suemoto H; Kawakatsu M; Tanishima H; Morimoto Y; Nishioka K; Hatamura I; Yoshida M; Muragaki Y
    Genes Cells; 2008 Apr; 13(4):355-63. PubMed ID: 18363966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
    Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A
    Nature; 1994 Sep; 371(6494):252-4. PubMed ID: 8078586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent.
    MacRae VE; Burdon T; Ahmed SF; Farquharson C
    J Endocrinol; 2006 Nov; 191(2):369-77. PubMed ID: 17088406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGFR3 isoforms have distinct functions in the regulation of growth and cell morphology.
    Shimizu A; Takashima Y; Kurokawa-Seo M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):113-20. PubMed ID: 11779141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biological action of parathyroid hormone-related peptide (PTHrP) and fibroblast growth factor receptor 3 (FGFR3) on bone and cartilage.
    Amizuka N; Ozawa H; Sasaki T
    Kaibogaku Zasshi; 2000 Oct; 75(5):415-25. PubMed ID: 11155687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor 1 inhibits hair cell apoptosis and promotes the cell cycle of supporting cells by activating different downstream cascades after pharmacological hair cell injury in neonatal mice.
    Hayashi Y; Yamamoto N; Nakagawa T; Ito J
    Mol Cell Neurosci; 2013 Sep; 56():29-38. PubMed ID: 23511189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.